Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
about
Targets for therapy in sarcomeric cardiomyopathiesResearch priorities in sarcomeric cardiomyopathiesAltered Calcium Handling and Ventricular Arrhythmias in Acute IschemiaRecent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian DescendantsEpigallocatechin-3-Gallate Accelerates Relaxation and Ca2+ Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice.Cardiac inotropy, lusitropy, and Ca2+ handling with major metabolic substrates in rat heartInvestigations into the Sarcomeric Protein and Ca2+-Regulation Abnormalities Underlying Hypertrophic Cardiomyopathy in Cats (Felix catus).Loss of the AE3 anion exchanger in a hypertrophic cardiomyopathy model causes rapid decompensation and heart failure.The dilated cardiomyopathy-causing mutation ACTC E361G in cardiac muscle myofibrils specifically abolishes modulation of Ca(2+) regulation by phosphorylation of troponin IMolecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.Single-sensor system for spatially resolved, continuous, and multiparametric optical mapping of cardiac tissue.Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathiesInsights into restrictive cardiomyopathy from clinical and animal studies.Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathy.Myofilament calcium de-sensitization and contractile uncoupling prevent pause-triggered ventricular tachycardia in mouse hearts with chronic myocardial infarctionImpaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomereFocal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments.Optical imaging of voltage and calcium in cardiac cells & tissuesProteasome dysfunction in cardiomyopathies.Current insights into LMNA cardiomyopathies: Existing models and missing LINCsLinking myofilaments to sudden cardiac death: recent advances.Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model.Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia.Familial hypertrophic cardiomyopathy: is the Frank-Starling law kaput?Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.Age- and strain-related aberrant Ca2+ release is associated with sudden cardiac death in the ACTC E99K mouse model of hypertrophic cardiomyopathy.Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.Neuronal nitric oxide synthase modulation of intracellular Ca2+ handling overrides fatty acid potentiation of cardiac inotropy in hypertensive rats.Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.Calcium in Brugada Syndrome: Questions for Future ResearchIsogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional DeficitsAssociation of cardiac myosin-binding protein-C with the ryanodine receptor channel - putative retrograde regulation?
P2860
Q27027023-3D651F90-C7AB-41DC-A793-4B119DDEBD8DQ27694507-782D8480-2E34-48E3-8809-E3D876EDE782Q28067531-8A2CF020-A9EA-4AED-B349-4F3957420613Q28075331-C2D353DF-E40C-4BDD-9EF7-295C9AD1ACCEQ30830714-3263CFA4-8CDE-409F-9C61-157DDB3C0401Q30830902-192427EB-F94E-49A6-8BAA-8C786680BF14Q33774621-A8168B52-DF59-4A9B-A84C-C8C2B48084E5Q34482398-7037E9FD-C66C-4309-91D4-B037A8A52B8CQ34561329-E5ACCF9D-D5D1-4689-8279-37E46D0808A0Q35144972-C59F2E10-F8F8-4E20-A873-9CE6572B341BQ35197369-9E7D166F-E425-4F36-B66D-EDBF38639E7AQ35936858-060E150C-22D0-46AE-B208-27A848AA3DEEQ36077266-032CF5E7-BF71-45B7-A8D4-F4B10936A0B3Q36923785-526B88A1-AACE-4FF7-A0D8-5161B097B356Q36931825-89E6326B-7169-45B0-B217-F6256D87A57DQ37054964-1150D217-79B3-49BF-B334-204FAC5365F9Q37363558-7BB8AB83-5E41-48BE-B25D-1FF6459A0D4FQ37985505-F4268427-60B0-4571-A08A-D49F974AF4ECQ38970493-B7C927B0-FF7D-4C7B-BCEF-62CD1B3BD2C1Q39104972-9FA0DFEA-B765-4413-86CE-27A8E271EB2FQ39138183-109DBB72-8D91-4401-902E-4B7A7EE54818Q39263982-310B7A9F-19D4-493D-8059-70C7F560CBECQ39397322-A516F2C6-B174-4DBB-B6CA-5F869C9E1541Q41203153-CEBE8E65-0EDE-4B80-96B0-4B95D54BA6F4Q41896456-36B09A70-3517-46FD-80D8-76E800943779Q42592709-A66C0165-2198-4748-B06F-583B829E42F0Q48747768-F021B258-001C-406A-8078-75D2104F399BQ50022359-FA212420-75BD-442E-9E87-BFC39B7E08B0Q50194792-3EE8020C-15C2-45E5-B3A1-4281FD793DD8Q50259289-EED3717A-1BBF-4A9D-AA53-FBB6EBF82C8AQ53110070-F1F80149-E1D5-43BE-926A-48EF432B1BB4Q54475335-986D77C9-3A56-4C50-BA41-F7F932CB7885Q57169914-BE70784B-B658-4F0D-B0C6-55E153C91FFFQ58577756-3632B32A-8A3B-49DC-8452-D6D56FBD16C5Q58801161-6DCD4891-57D7-4056-B9D4-843B1FC1CA98
P2860
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
@en
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
@nl
type
label
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
@en
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
@nl
prefLabel
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
@en
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.
@nl
P2860
P1476
Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility
@en
P2093
Sabine Huke
P2860
P304
P356
10.1016/J.YJMCC.2010.01.011
P577
2010-01-22T00:00:00Z